Clinical trial
A Prospective Clinical Study of Proton Moderately Hypofractionated Radiotherapy for Non-Small Cell Lung Cancer Patients Unable to Tolerate Standard Concurrent Chemoradiotherapy
NCT07919691 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Clinical Study of Proton Moderately Hypofractionated Radiotherapy for Non-Small Cell Lung Cancer Patients Unable to Tolerate Standard Concurrent Chemoradiotherapy
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2030
- Enrollment
- 44 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer
Lead sponsor's other trials
Ruijin Hospital, most recent start first.
+673 more trials See the organization page
Similar trials
Same condition (Carcinoma, Non-Small-Cell Lung) and phase, most recent start first.
+2,324 more trials See the condition page